Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Noema Pharma
Biotech
Noema ticks off phase 2a Tourette win for ex-Roche molecule
Noema reported hits on the primary and key secondary endpoints in a small study of the former Roche molecule.
Nick Paul Taylor
Oct 17, 2024 9:35am
Guth takes reins of Bayer’s US operations—Chutes & Ladders
Jun 23, 2023 9:30am
Noema bags $60M to take ex-Roche CNS drugs through phase 2b
Dec 1, 2020 8:38am
